Celcuity Inc

CELCNASDAQ · USD
79.52USD0.00 (+0.19%)
119

Celcuity Inc (CELC) Covered Calls

As of September 25, 2026, CELC has 80 covered call opportunities in the coming three months. Return ranges from 3.6 to 177.9% until expiration. Annualized return ranges from 17.6 to 253.1%. The nearest expiration is October 16, 2026. Maximum potential profit is $14,148.

Read more

Running CELC covered calls helps you generate consistent income from Celcuity Inc's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Celcuity Inc involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best CELC covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.

A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if CELC stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling CELC covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Celcuity Inc covered call is worth writing.

Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment. Its drug candidate includes Gedatolisib, which selectively targets various class I isoforms of PI3K and mammalian target of rapamycin and focus on the treatment of patients with hormone receptor positive, HER2-negative, and advanced or metastatic breast cancer.

The company is also developing CELsignia MP test, a qualitative laboratory developed test that measures HER2, c-Met, and PI3K signaling activity in breast and ovarian tumor cells. It had a license agreement with Pfizer, Inc. for the development and commercialization rights to Gedatolisib. Celcuity Inc. was founded in 2011 and is headquartered in Minneapolis, Minnesota.

Income-focused investors, long-term CELC holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling CELC covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Celcuity Inc covered calls come to you, already filtered for the metrics that matter.

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV percentile60.32% Neutral
  • Market cap (M$)3,891
  • 52 weeks high-47.34%
  • 52 weeks low79.02%
  • Analyst recommendationStrong Buy
    1.00
  • Target price$160.75
    102.15% above the current stock price
  • Dividend—
  • Payout ratio—
  • Earnings date2026-11-11
  • P/E—
  • Future P/E—
  • EPS (ttm)-4.30
  • EPS growth next 5 years—

As of September 25, 2026

2026-11-2056110.0038.330.401.203088.0038.83253.11-0.50+0.10210.80
2027-01-15112140.0076.060.202.206068.0076.31248.68-0.25+0.10102.00
2026-10-162190.0013.180.652.201113.0014.00243.27-0.82+0.232511.55
2026-11-2056105.0032.040.103.102558.0032.17209.67-0.13+0.1713.00
2027-01-15112125.0057.190.053.204553.0057.26186.59-0.06+0.141943.15
2026-11-2056100.0025.750.753.702123.0026.70174.01-0.94+0.22162.95
2027-03-19175145.0082.340.053.406553.0082.41171.88-0.06+0.1203.35
2027-01-15112120.0050.910.303.804078.0051.28167.13-0.38+0.16573.50
2026-12-1884110.0038.330.103.803058.0038.46167.10-0.13+0.183303.70
2027-03-19175140.0076.060.653.806113.0076.87160.34-0.82+0.1523.15

As of September 25, 2026

Sell covered calls with the data behind you

Find the best CELC covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.

Start your 14-day free trial